Publications by authors named "Seung Ki Kwok"

Background/aims: Interstitial lung disease (ILD) is a potentially serious but underdiagnosed manifestation of primary Sjögren's syndrome (pSS). This observational study investigated the prevalence and clinical course of ILD in pSS, together with prognostic factors.

Methods: A multicenter, retrospective longitudinal study was performed using findings from baseline and follow-up pulmonary function tests and chest computed tomography.

View Article and Find Full Text PDF

Objective: This study aimed to elucidate the clinical and laboratory differences between chronic sclerosing sialadenitis (CSS) and primary Sjögren's syndrome (pSS), highlighting CSS as a distinct pathological entity within the spectrum of salivary gland pathology.

Methods: This retrospective, single-center study was conducted at Seoul St. Mary's Hospital between January 2000 and December 2022.

View Article and Find Full Text PDF

Follicular helper T (T) cells mediate germinal center reactions to generate high affinity antibodies against specific pathogens, and their excessive production is associated with the pathogenesis of systemic autoimmune diseases such as systemic lupus erythematosus (SLE). ETV5, a member of the ETS transcription factor family, promotes T cell differentiation in mice. In this study, we examined the role of ETV5 in the pathogenesis of lupus in mice and humans.

View Article and Find Full Text PDF

Background/aims: Renal relapse has known to be a poor prognostic factor in patients with lupus nephritis (LN), but there were few studies that identified the risk factors of renal relapse in real world. We conducted this study based on 35-years of experience at a single center to find out predictors of renal relapse in Korean patients with LN after achieving complete response (CR).

Methods: We retrospectively analyzed the clinical, laboratory, pathologic and therapeutic parameters in 296 patients of LN who reached CR.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness and safety of intravenous belimumab in South Korean patients with systemic lupus erythematosus (SLE) who participated in a larger trial known as the North East Asia (NEA) study.
  • The analysis found that significantly more patients receiving belimumab (53.0%) achieved a key treatment response compared to those on placebo (23.5%), with similar rates of adverse events reported in both groups.
  • Overall, belimumab showed to be both effective and well tolerated for treating SLE in this specific patient subgroup.
View Article and Find Full Text PDF

Background/aims: We aimed to clarify the clinical characteristics of psoriatic arthritis (PsA) in Korean patients focusing on PsA with axial involvement.

Methods: A retrospective medical chart review was performed to identify PsA patients at a single tertiary center. Cases of AS patients with psoriasis were recruited from a prospective AS registry of the same center.

View Article and Find Full Text PDF
Article Synopsis
  • This study analyzed how demographic and clinical factors at baseline can predict the development of systemic lupus erythematosus (SLE) in patients with Sjögren's syndrome (SS).
  • Researchers evaluated data from 1,082 SS patients over a median follow-up of about 3 years, finding that 4.5% developed SLE, with significant predictors identified including high disease activity scores and certain blood abnormalities.
  • Key predictors for SLE development include shorter SS disease duration, higher disease activity (measured by ESSDAI), and specific serological markers, indicating a need for careful monitoring of patients with these risk factors.
View Article and Find Full Text PDF

Systemic rheumatic diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, are chronic autoimmune diseases affecting multiple organs and tissues. Despite recent advances in treatment, patients still experience significant morbidity and disability. Mesenchymal stem/stromal cell (MSC)-based therapy is promising for treating systemic rheumatic diseases due to the regenerative and immunomodulatory properties of MSCs.

View Article and Find Full Text PDF

Background/aims: We aimed to compare the effectiveness and safety of Janus kinase inhibitors (JAKi) vs. biologic disease- modifying antirheumatic drugs (bDMARD) in Korean patients with rheumatoid arthritis (RA) who had an inadequate response to conventional synthetic DMARDs.

Methods: A quasi-experimental, multi-center, prospective, non-randomized study was conducted to compare response rates between JAKi and bDMARDs in patients with RA naïve to targeted therapy.

View Article and Find Full Text PDF

Introduction: Dysbiosis is an environmental factor that affects the induction of axial spondyloarthritis (axSpA) pathogenesis. In the present study, we investigated differences in the gut microbiota of patients with axSpA and revealed an association between specific gut microbiota and their metabolites, and SpA pathogenesis.

Method: Using 16S rRNA sequencing data derived from feces samples of 33 axSpA patients and 20 healthy controls (HCs), we examined the compositions of their gut microbiomes.

View Article and Find Full Text PDF

Objectives: Few studies have examined factors affecting steroid-free remission (SFR) in patients with immunoglobulin G4-related disease (IgG4-RD). The aim of this study was to investigate clinical factors affecting SFR in IgG4-RD.

Methods: The medical records of 68 patients who met the 2020 revised comprehensive diagnostic criteria for IgG4-RD were reviewed retrospectively.

View Article and Find Full Text PDF

Objectives: Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease with low quality of life caused by various constitutional symptoms and glandular dysfunction. Although fatigue is one of the most frequent symptoms in pSS, its aetiology or biomarkers are poorly elucidated. We investigated potential relationship between severity of fatigue and the kynurenine pathway in pSS.

View Article and Find Full Text PDF

Liver X receptor (LXR) is a critical regulator of cholesterol homeostasis that inhibits T cell receptor (TCR)-induced proliferation by altering intracellular sterol metabolism. However, the mechanisms by which LXR regulates helper T cell subset differentiation remain unclear. Here, we demonstrate that LXR is a crucial negative regulator of follicular helper T (Tfh) cells in vivo.

View Article and Find Full Text PDF

Association between exposure to periodontal bacteria and development of autoantibodies related to rheumatoid arthritis (RA) has been widely accepted; however, direct causal relationship between periodontal bacteria and rheumatoid factor (RF) is currently not fully understood. We investigated whether periodontal bacteria could affect RF status. Patients with preclinical, new-onset, or chronic RA underwent periodontal examination, and investigation of subgingival microbiome via 16S rRNA sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • * The study identifies elevated levels of mitochondrial double-stranded RNAs (mt-dsRNAs) in saliva and tears of SS patients and explores their influence on immune responses and glandular function.
  • * Findings suggest that mt-dsRNAs activate the immune system through the JAK1/STAT pathway, contributing to SS pathology and presenting a potential therapeutic target to alleviate autoimmune symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Sjögren syndrome (SS) is an autoimmune disease characterized by the infiltration of immune cells into exocrine glands, prompting the need for treatments that regulate immune responses.
  • Sphingosylphosphorylcholine (SPC) is a sphingolipid that plays a role in immune cell signaling and exhibits immunomodulatory effects.
  • In a study involving SPC treatment on female NOD mice, it was found that SPC reduced inflammation in salivary glands, maintained saliva flow, and enhanced the presence of regulatory B cells and salivary secretion markers, indicating its potential as a therapeutic agent for SS.
View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to assess how the time-averaged disease activity score (DAS)28 and Health Assessment Questionnaire (HAQ) relate to cardiovascular disease (CVD) risk in rheumatoid arthritis (RA) patients.
  • - Researchers analyzed data from over 4,000 RA patients, categorizing them by their DAS28 scores and finding that a higher score correlated with an increased incidence of CVD events.
  • - The findings indicate that both higher time-averaged DAS28 and HAQ scores are significant predictors of CVD in RA patients, suggesting that monitoring these factors could help assess cardiovascular risk.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes 414 patients with primary Sjögren's syndrome (SS) who developed hematological malignancies, focusing on their patterns and outcomes.
  • 91% of patients had mature B-cell malignancies, predominantly mucosa-associated lymphoid tissue (MALT) lymphoma, with varied clinical presentations and responses to treatment.
  • The findings highlight a high prevalence of B-cell lymphomas, particularly MALT lymphoma, with significant age and survival differences among different types of malignancies linked to SS.
View Article and Find Full Text PDF
Article Synopsis
  • Systemic autoimmune diseases result from a breakdown in the body’s ability to distinguish between self and non-self, leading to immune system issues.
  • Current treatments range from general immunosuppressants to targeted therapies, but these often fail to restore immune tolerance in patients.
  • New research focuses on using specific immune-regulating cell types like mesenchymal stromal cells, Tregs, and myeloid-derived suppressor cells to improve treatment effectiveness, with ongoing studies exploring their mechanisms and challenges in clinical applications.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic kidney disease (CKD) significantly impacts health outcomes in patients with lupus nephritis (LN), yet there’s limited research on its development within this group.
  • A study analyzed 401 LN patients over 35 years to identify factors predicting CKD risk, finding that 15.5% developed CKD within 10 years post-diagnosis.
  • Key predictors for CKD included delayed-onset LN, acute renal dysfunction at diagnosis, and insufficient treatment response at 6 or 12 months, rather than initial severity of kidney damage or protein levels.
View Article and Find Full Text PDF

B-1 cell development mainly occurs via fetal and neonatal hematopoiesis and is suppressed in adult bone marrow hematopoiesis. However, little is known about the factors inhibiting B-1 cell development at the adult stage. We report that capicua (CIC) suppresses postnatal B-1a cell development and survival.

View Article and Find Full Text PDF

Objective: CR6-interacting factor 1 (CRIF1) is a nuclear transcriptional regulator and a mitochondrial inner membrane protein; however, its functions in B lymphocytes have been poorly defined. This study was undertaken to investigate the effects of CRIF1 on B cell metabolic regulation, cell function, and autoimmune diseases.

Methods: Using mice with B cell-specific deletion of CRIF1 (Crif1 mice), we assessed the relevance of CRIF1 function for lupus disease parameters, including anti-double-stranded DNA (anti-dsDNA), cytokines, and kidney pathology.

View Article and Find Full Text PDF

Objective: To investigate whether initial whole spine magnetic resonance imaging (MRI) predicts radiographic progression and inflammatory activity in patients with axial spondyloarthritis (axSpA).

Methods: A retrospective analysis of spine MRI and X-rays from 70 axSpA patients was conducted. The number of affected discovertebral units was determined according to the definition of pathologic lesions on spine MRI set down by the ASAS/OMERACT group.

View Article and Find Full Text PDF

Group 3 innate lymphoid cells (ILC3), which express IL-22 and IL-17A, has been introduced as one of pathologic cells in axial spondyloarthritis (axSpA). Dyslipidaemia should be managed in axSpA patients to reduce cardiovascular disease, and dyslipidaemia promotes inflammation. This study aimed to reveal the role of circulating ILC3 in axSpA and the impact of dyslipidaemia on axSpA pathogenesis.

View Article and Find Full Text PDF